$Prognostic model for relapsed/refractory transplant-ineligible diffuse large B-cell lymphoma utilizing the lymphocyte-to-monocyte ratio$

Prognostic model for relapsed/refractory transplant-ineligible diffuse large B-cell lymphoma utilizing the lymphocyte-to-monocyte ratio

We conducted a multi-institutional retrospective study in 100 transplant-ineligible (TI) patients with diffuse large B-cell lymphoma (DLBCL) that relapsed or progressed after first-line R-CHOP (or -like) therapy to develop a robust predictive model for TI relapsed/refractory (r/r) DLBCL, which has a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of hematology 2024-06, Vol.119 (6), p.697-706
Hauptverfasser:	Ide, Daisuke, Fujino, Takahiro, Kobayashi, Tsutomu, Egashira, Aya, Miyashita, Akihiro, Mizuhara, Kentaro, Isa, Reiko, Tsukamoto, Taku, Mizutani, Shinsuke, Uchiyama, Hitoji, Kaneko, Hiroto, Uoshima, Nobuhiko, Kawata, Eri, Taniwaki, Masafumi, Shimura, Yuji, Kuroda, Junya
Format:	Artikel
Sprache:	eng
Schlagworte:	B-cell lymphoma Bispecific antibodies C-reactive protein Chimeric antigen receptors Decision making Hematology L-Lactate dehydrogenase Lactate dehydrogenase Lymphocytes Lymphocytes B Lymphocytes T Lymphoma Medical prognosis Medicine Medicine & Public Health Monocytes Multivariate analysis Oncology Original Article Prediction models Prognosis Survival Therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!